Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORA: Comprehensive Treatment of Angina in Women With Microvascular Dysfunction
NCT02910154Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Dec 2016
- Primary completion
- Oct 2018
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Coronary Flow Velocity Reserve at 24 months. Started Dec 2016; status: completed.
Beyond the preview
Go deeper on NCT02910154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910154.